Forte Biosciences News - FBRX

Company Name	Stock Ticker Symbol	Market	Type
Forte Biosciences Inc	FBRX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.01	-1.28%	0.77	13:16:40

Open Price	Low Price	High Price	Close Price	Prev Close
0.78	0.75	0.78		0.78

more quote information »

Recent News

Date	Time	Source	Heading
2/16/2024	16:16	EDGAR2	Form 8-K/A - Current report: [Amend]
2/14/2024	16:54	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
1/05/2024	17:27	EDGAR2	Form SC 13D/A - General statement of acquisition of..
1/03/2024	16:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	16:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/20/2023	10:56	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	18:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/12/2023	19:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/08/2023	19:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/08/2023	16:05	EDGAR2	Form 8-K - Current report
11/22/2023	17:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/13/2023	16:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/03/2023	16:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/03/2023	16:26	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/26/2023	16:16	EDGAR2	Form 8-K/A - Current report: [Amend]
9/20/2023	17:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/20/2023	17:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/20/2023	17:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/20/2023	17:49	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/20/2023	17:48	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/20/2023	16:15	EDGAR2	Form 8-K - Current report
9/20/2023	16:05	EDGAR2	Form 8-K - Current report
9/14/2023	16:00	EDGAR2	Form DFAN14A - Additional definitive proxy soliciting..
9/14/2023	10:50	BW	ISS and Glass Lewis Recommend Forte Biosciences Stockholders..
9/11/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
9/08/2023	16:36	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
9/06/2023	16:31	EDGAR2	Form DFAN14A - Additional definitive proxy soliciting..
9/06/2023	15:15	BW	Concerned Stockholders of Forte Biosciences and Its..
9/01/2023	17:25	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
8/31/2023	17:29	EDGAR2	Form DFAN14A - Additional definitive proxy soliciting..
8/31/2023	14:31	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
8/29/2023	17:57	EDGAR2	Form S-3 - Registration statement under Securities Act of..
8/25/2023	17:17	EDGAR2	Form DFAN14A - Additional definitive proxy soliciting..
8/25/2023	10:10	EDGAR2	Form DEFC14A - Definitive proxy statement, contested..
8/25/2023	08:00	BW	Concerned Stockholders of Forte Biosciences File Definitive..
8/24/2023	06:15	EDGAR2	Form DEFC14A - Definitive proxy statement, contested..
8/23/2023	16:47	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
8/17/2023	09:30	EDGAR2	Form PRRN14A - Non-management revised preliminary proxy..
8/15/2023	17:15	EDGAR2	Form SC 13D/A - General statement of acquisition of..
8/14/2023	17:01	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	09:20	EDGAR2	Form SC 13D/A - General statement of acquisition of..
8/04/2023	16:21	EDGAR2	Form 8-K - Current report
8/03/2023	16:31	EDGAR2	Form SC 13D/A - General statement of acquisition of..
8/02/2023	18:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/02/2023	18:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/02/2023	17:58	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/02/2023	17:56	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/02/2023	17:28	EDGAR2	Form PREC14A - Preliminary proxy statements, contested..
8/01/2023	16:06	EDGAR2	Form 8-K - Current report
7/06/2023	16:08	EDGAR2	Form SC 13D/A - General statement of acquisition of..